logo

Cocrystal Pharma, Inc. (COCP)



Trade COCP now with
  Date
  Headline
12/22/2020 8:48:39 AM Cocrystal Pharma Selects Lead Compound CDI-45205 For Further Development Against Coronaviruses
4/20/2020 8:13:48 AM Cocrystal Pharma Names Roger Kornberg To Board
9/3/2019 8:28:54 AM Cocrystal Pharma Presents Positive Preclinical Data For CC-42344 At The Options X For Control Of Influenza Conference
8/21/2019 8:11:16 AM Cocrystal Pharma Says Abstract Accepted For Oral Presentation At ISIRV: Options X For Control Of Influenza Conference
1/22/2019 8:07:04 AM Cocrystal Pharma Provides Update On Clinical Development Program Evaluating CC-31244 For Ultra-Short Treatment Of HCV